Haleon plc Overview
Pro stress-test →Haleon is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other.
Strategic Profile
Pro stress-test →The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip. Haleon announced it is evolving its operating model in support of its Win as One strategy to drive its growth, productivity and culture agenda, with implementation expected by mid-2026, representing a transformation into a world-class consumer company.
Competitive Landscape
Pro stress-test →Kenvue and Procter & Gamble Hygiene and Health Care are competitors of Haleon. Haleon holds leading positions in oral care, pain relief, and nutrition categories through established global brands. The company differentiates through its diversified portfolio spanning six major health categories and significant emerging market presence.
Industry Context
Haleon plc operates in Consumer Health / Over-the-Counter (OTC) Healthcare Products.
Key facts
Founded: 1715 · Headquarters: Weybridge, United Kingdom · Revenue: $14.2B · Market cap: $49.6B